Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer.

Godlewski J, Lenart J, Salinska E.

Noncoding RNA. 2019 Feb 23;5(1). pii: E20. doi: 10.3390/ncrna5010020. Review.

2.

MicroRNAs in cancers and neurodegenerative disorders.

Saito Y, Saito H.

Front Genet. 2012 Sep 26;3:194. doi: 10.3389/fgene.2012.00194. eCollection 2012.

3.

MicroRNAs in brain development and degeneration.

Enciu AM, Popescu BO, Gheorghisan-Galateanu A.

Mol Biol Rep. 2012 Mar;39(3):2243-52. doi: 10.1007/s11033-011-0973-1. Epub 2011 Jun 5. Review.

PMID:
21643950
4.

MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms.

Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R.

PLoS One. 2013;8(1):e54222. doi: 10.1371/journal.pone.0054222. Epub 2013 Jan 17.

5.

Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.

Dinda B, Dinda M, Kulsi G, Chakraborty A, Dinda S.

Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Review.

PMID:
30877973
6.

Long non-coding RNAs in Huntington's disease neurodegeneration.

Johnson R.

Neurobiol Dis. 2012 May;46(2):245-54. doi: 10.1016/j.nbd.2011.12.006. Epub 2011 Dec 14. Review.

PMID:
22202438
7.

Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.

Wang H, Li Y, Ryder JW, Hole JT, Ebert PJ, Airey DC, Qian HR, Logsdon B, Fisher A, Ahmed Z, Murray TK, Cavallini A, Bose S, Eastwood BJ, Collier DA, Dage JL, Miller BB, Merchant KM, O'Neill MJ, Demattos RB.

Mol Neurodegener. 2018 Dec 17;13(1):65. doi: 10.1186/s13024-018-0296-y.

8.

Regulatory triangle of neurodegeneration, adult neurogenesis and microRNAs.

Singh T, Jauhari A, Pandey A, Singh P, Pant AB, Parmar D, Yadav S.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):96-103. Review.

PMID:
24152328
9.

MicroRNAs in Neurodegenerative Diseases.

Quinlan S, Kenny A, Medina M, Engel T, Jimenez-Mateos EM.

Int Rev Cell Mol Biol. 2017;334:309-343. doi: 10.1016/bs.ircmb.2017.04.002. Epub 2017 Jun 16. Review.

PMID:
28838542
10.

The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.

Czubowicz K, Jęśko H, Wencel P, Lukiw WJ, Strosznajder RP.

Mol Neurobiol. 2019 Jan 5. doi: 10.1007/s12035-018-1448-3. [Epub ahead of print] Review.

PMID:
30612333
11.

MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.

Saraiva C, Esteves M, Bernardino L.

Biochem Pharmacol. 2017 Oct 1;141:118-131. doi: 10.1016/j.bcp.2017.07.008. Epub 2017 Jul 11. Review.

PMID:
28709951
12.

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration.

Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ.

Front Cell Neurosci. 2013 Oct 10;7:178. doi: 10.3389/fncel.2013.00178. Review.

13.

MicroRNAs in Parkinson's disease.

Singh A, Sen D.

Exp Brain Res. 2017 Aug;235(8):2359-2374. doi: 10.1007/s00221-017-4989-1. Epub 2017 May 19. Review.

PMID:
28526930
14.

Dysregulated microRNAs in neurodegenerative disorders.

Lau P, de Strooper B.

Semin Cell Dev Biol. 2010 Sep;21(7):768-73. doi: 10.1016/j.semcdb.2010.01.009. Epub 2010 Jan 18. Review.

PMID:
20080199
15.

Techniques and Methods of Animal Brain Surgery: Perfusion, Brain Removal, and Histological Techniques.

Soueid J, Nokkari A, Makoukji J.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 15.

16.

Pathomechanisms of TDP-43 in neurodegeneration.

Gao J, Wang L, Huntley ML, Perry G, Wang X.

J Neurochem. 2018 Feb 27. doi: 10.1111/jnc.14327. [Epub ahead of print] Review.

17.

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.

Gao J, Wang L, Liu J, Xie F, Su B, Wang X.

Antioxidants (Basel). 2017 Apr 5;6(2). pii: E25. doi: 10.3390/antiox6020025. Review.

18.

Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities.

Merelli A, Rodríguez JCG, Folch J, Regueiro MR, Camins A, Lazarowski A.

Curr Neuropharmacol. 2018;16(10):1484-1498. doi: 10.2174/1570159X16666180110130253. Review.

PMID:
29318974
19.

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG.

BMC Med. 2008 Jun 24;6:14. doi: 10.1186/1741-7015-6-14.

20.

Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).

Pogue AI, Lukiw WJ.

Cell Mol Neurobiol. 2018 Jul;38(5):1021-1031. doi: 10.1007/s10571-017-0572-3. Epub 2018 Jan 4.

PMID:
29302837

Supplemental Content

Support Center